Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![USCorpFilings Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1859110030752313345.png) SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4397 followers
Created: 2025-07-25 21:00:08 UTC

$BMY Appointments:

On July 25, 2025, Bristol-Myers Squibb announced that Dr. Samit Hirawat will leave his role as Chief Medical Officer by November 1, 2025, and will serve as an advisor starting August 1, 2025. He will receive severance benefits, pro-rated equity vesting, and an incentive payout for 2025.




XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948850781488382157/c:line.svg)

**Related Topics**
[sec](/topic/sec)
[$bmy](/topic/$bmy)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/USCorpFilings/status/1948850781488382157)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

USCorpFilings Avatar SEC Filings Digest @USCorpFilings on x 4397 followers Created: 2025-07-25 21:00:08 UTC

$BMY Appointments:

On July 25, 2025, Bristol-Myers Squibb announced that Dr. Samit Hirawat will leave his role as Chief Medical Officer by November 1, 2025, and will serve as an advisor starting August 1, 2025. He will receive severance benefits, pro-rated equity vesting, and an incentive payout for 2025.

XXX engagements

Engagements Line Chart

Related Topics sec $bmy stocks healthcare

Post Link

post/tweet::1948850781488382157
/post/tweet::1948850781488382157